PRNewsWire - Health

Design 1st Embedded Software Expertise Transforms Lab-Only Breath Analysis into Award-Winning Consumer Wearable
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
CCA Industries, Inc. Reports Results of Operations for the Quarter ended February 28, 2025
Takeda's ENTYVIO Continues Growth Trajectory in Ulcerative Colitis and Crohn's Disease | DelveInsight